Cancer Research UK scientists have created the first 3D structure of a key protein that protects against the development of cancer, according to research published in Nature Structural & Molecular Biology.
23 January, 2012
Pain therapy drug developers address the rapid rise in prescription drug abuse alongside the need for safe and effective treatments for a growing number of chronic pain sufferers. The sector has a diverse pipeline, with reformulations of existing therapies and alternative modes of drug delivery in development alongside novel compounds. However, increased generic competition will temper market growth over the next decade.
23 January, 2012
Development charity Sightsavers has today unveiled a 10-year campaign to help eliminate one of the world’s leading causes of preventable blindness, termed onchocerciasis (also river blindness). With plans to fundraise and invest more than £27 million over the next decade to help combat this neglected tropical disease (NTD) across Africa, the charity is starting work this month in the Democratic Republic of the Congo where the disease is endemic.
17 January, 2012
Scientists based at Cancer Research UK’s Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse, according to a study published in Nature.
05 January, 2012